Tranexamic Acid

CAS 1197-18-8 10 current records 3 historicalSmall Molecule

Who holds supplier records for Tranexamic Acid? 10 organisations hold a current record for Tranexamic Acid: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (4), China (3) and Japan (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Tranexamic Acid: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/tranexamic-acid

Reading the evidence

  • 10 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (10)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Tranexamic Acid. Country is the organisation's recorded country, not necessarily the manufacturing site.

India4China3Japan1Country not recorded for 2
Need Tranexamic Acid sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Tranexamic Acid, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG BAMBOO PHARMACEUTICALS CO.,LTD. ShaoxingCN
CEP 2025-258 - Rev 02
Tranexamic acid
Sept 2026—
JIANGSU TIANHE PHARMACEUTICAL CO., LTD. YangzhouCN
CEP 2023-449 - Rev 00
Tranexamic acid
Apr 2026—
AMI LIFESCIENCES PRIVATE LIMITED VadodaraIN
CEP 2019-250 - Rev 04
Tranexamic acid
Sept 2025Inspected Oct 2025
Slovakia
SHILPA PHARMA LIFESCIENCES LIMITED RaichurIN
CEP 2018-048 - Rev 02
Tranexamic acid
Oct 2024—
MALLADI DRUGS AND PHARMACEUTICALS LIMITED RanipetIN
CEP 2022-243 - Rev 00
Tranexamic acid
Sept 2024—
Hunan Dongting Pharmaceutical Co. Ltd ChangdeCN
R1-CEP 2006-142 - Rev 03
Tranexamic acid
Jun 2023—
KYOWA PHARMA CHEMICAL CO., LTD. TakaokaJP
R1-CEP 2012-271 - Rev 02
Tranexamic acid
Sept 2022—
ASAHI KASEI FINECHEM CO., LTD. OsakaJP
R1-CEP 2008-186 - Rev 01
Tranexamic acid
May 2020—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Tranexamic Acid are no longer active. These show a past filing, not current supply.

Show all 3 historical records

Overview

Tranexamic Acid is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL877).

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Antifibrinolytic Agent
Physiologic effect
Decreased Fibrinolysis

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Tranexamic Acid?

10 organisations hold an active US FDA Type II Drug Master File or a CEP for Tranexamic Acid: AMI LIFESCIENCES PRIVATE LTD (India), ASAHI KASEI FINECHEM CO LTD, HUNAN DONGTING PHARMACEUTICAL CO LTD (China), KYOWA PHARMA CHEMICAL CO LTD (Japan), MALLADI DRUGS AND PHARMACEUTICALS LTD (India), SHILPA PHARMA LIFESCIENCES LTD (India), Zhejiang Bamboo Pharmaceuticals Co.,Ltd (China) and ALP PHARM BEIJING CO LTD, and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Tranexamic Acid Drug Master Files are active?

AMI LIFESCIENCES PRIVATE LTD (DMF 36336), ASAHI KASEI FINECHEM CO LTD (DMF 25331), HUNAN DONGTING PHARMACEUTICAL CO LTD (DMF 14181), KYOWA PHARMA CHEMICAL CO LTD (DMF 26128), MALLADI DRUGS AND PHARMACEUTICALS LTD (DMF 37130), SHILPA PHARMA LIFESCIENCES LTD (DMF 33086), Zhejiang Bamboo Pharmaceuticals Co.,Ltd (DMF 41407) and ALP PHARM BEIJING CO LTD (DMF 22277) and 1 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Tranexamic Acid records mean?

3 organisations have only inactive Type II DMFs for Tranexamic Acid. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Tranexamic Acid have a European Certificate of Suitability?

Yes. 8 organisations hold a valid CEP for Tranexamic Acid on the EDQM register, including ZHEJIANG BAMBOO PHARMACEUTICALS CO.,LTD. Shaoxing (CN), JIANGSU TIANHE PHARMACEUTICAL CO., LTD. Yangzhou (CN), AMI LIFESCIENCES PRIVATE LIMITED Vadodara (IN), SHILPA PHARMA LIFESCIENCES LIMITED Raichur (IN), MALLADI DRUGS AND PHARMACEUTICALS LIMITED Ranipet (IN) and Hunan Dongting Pharmaceutical Co. Ltd Changde (CN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Tranexamic Acid supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Tranexamic Acid?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.